{"uri": "eng-9411300", "concepts": [{"uri": "http://en.wikipedia.org/wiki/Metastatic_breast_cancer", "type": "wiki", "score": 100, "label": {"eng": "Metastatic breast cancer"}}, {"uri": "http://en.wikipedia.org/wiki/Biotechnology", "type": "wiki", "score": 98, "label": {"eng": "Biotechnology"}}, {"uri": "http://en.wikipedia.org/wiki/Food_and_Drug_Administration", "type": "wiki", "score": 98, "label": {"eng": "Food and Drug Administration"}}, {"uri": "http://en.wikipedia.org/wiki/Hormonal_therapy_(oncology)", "type": "wiki", "score": 78, "label": {"eng": "Hormonal therapy (oncology)"}}, {"uri": "http://en.wikipedia.org/wiki/Hormone", "type": "wiki", "score": 76, "label": {"eng": "Hormone"}}, {"uri": "http://en.wikipedia.org/wiki/Investigational_New_Drug", "type": "wiki", "score": 72, "label": {"eng": "Investigational New Drug"}}, {"uri": "http://en.wikipedia.org/wiki/Endocrine_system", "type": "wiki", "score": 72, "label": {"eng": "Endocrine system"}}, {"uri": "http://en.wikipedia.org/wiki/Drug_development", "type": "wiki", "score": 71, "label": {"eng": "Drug development"}}, {"uri": "http://en.wikipedia.org/wiki/Efficacy", "type": "wiki", "score": 66, "label": {"eng": "Efficacy"}}, {"uri": "http://en.wikipedia.org/wiki/Biomarker", "type": "wiki", "score": 56, "label": {"eng": "Biomarker"}}, {"uri": "http://en.wikipedia.org/wiki/Epidermal_growth_factor_receptor", "type": "wiki", "score": 55, "label": {"eng": "Epidermal growth factor receptor"}}, {"uri": "http://en.wikipedia.org/wiki/Metastasis", "type": "wiki", "score": 53, "label": {"eng": "Metastasis"}}, {"uri": "http://en.wikipedia.org/wiki/Exemestane", "type": "wiki", "score": 48, "label": {"eng": "Exemestane"}}, {"uri": "http://en.wikipedia.org/wiki/Anastrozole", "type": "wiki", "score": 48, "label": {"eng": "Anastrozole"}}, {"uri": "http://en.wikipedia.org/wiki/Cyclin-dependent_kinase", "type": "wiki", "score": 42, "label": {"eng": "Cyclin-dependent kinase"}}, {"uri": "http://en.wikipedia.org/wiki/Tamoxifen", "type": "wiki", "score": 42, "label": {"eng": "Tamoxifen"}}, {"uri": "http://en.wikipedia.org/wiki/Letrozole", "type": "wiki", "score": 42, "label": {"eng": "Letrozole"}}, {"uri": "http://en.wikipedia.org/wiki/Fulvestrant", "type": "wiki", "score": 36, "label": {"eng": "Fulvestrant"}}, {"uri": "http://en.wikipedia.org/wiki/Progression-free_survival", "type": "wiki", "score": 35, "label": {"eng": "Progression-free survival"}}, {"uri": "http://en.wikipedia.org/wiki/Phases_of_clinical_research", "type": "wiki", "score": 35, "label": {"eng": "Phases of clinical research"}}], "eventDate": "2024-03-20", "totalArticleCount": 5, "title": {"eng": "FDA clears Puma Biotech's Phase II of alisertib, a treatment for breast cancer By Investing.com"}, "summary": {"eng": "LOS ANGELES - Puma Biotechnology, Inc. (NASDAQ:PBYI) has received the green light from the U.S. Food and Drug Administration (FDA) to proceed with a Phase II clinical trial for its investigational drug alisertib, intended for patients with a specific type of metastatic breast cancer.\n\nThe trial, named ALISCA-Breast1 (Study PUMA-ALI-4201), is set to begin in the second half of 2024 and will focus on individuals with hormone receptor-positive, HER2-negative metastatic breast cancer who have previou"}, "location": null, "categories": [{"uri": "dmoz/Health/Teen_Health/Drugs_and_Alcohol", "label": "dmoz/Health/Teen Health/Drugs and Alcohol", "wgt": 100}, {"uri": "dmoz/Health/Men's_Health/Conditions_and_Diseases", "label": "dmoz/Health/Men's Health/Conditions and Diseases", "wgt": 100}, {"uri": "news/Business", "label": "news/Business", "wgt": 78}], "articleCounts": {"eng": 5}, "sentiment": -0.1294117647058823, "wgt": 448588800, "relevance": 1}